Miller Deborah Ann — SEC Form 4 filings
SEC reporting owner CIK 1868741. 24 Form 4 filings on record with FilingPulse; latest filed 2026-07-15.
Transaction summary — filings shown
Covers all 24 filings on record, filed 2024-01-09 to 2026-07-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 83 legs across 22 filings — 205,916 shares, $19,248,276 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 66.
- Largest priced transaction: sale of 15,075 shares @ $105.16 ($1,585,287) in Nuvalent, Inc., filed 2025-11-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Nuvalent, Inc. (NUVL) | Chief Legal Officer | 24 | — | 83 legs · 205,916 sh · $19,248,276 | 66 |
Form 4 filings — Miller Deborah Ann
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-15 | 4 | Nuvalent, Inc. (NUVL) | Code (U): 18,534 @ $124 · Disposition to issuer (D): 41,100 · Grant/award (A): 14,350 @ $0 · Disposition to issuer (D): 14,350 · Disposition to issuer (D): 72,608 (derivative) · Disposition to issuer (D): 61,000 (derivative) · +4 more | EDGAR |
| 2026-06-01 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 5,500 @ $6.89 · Sale (S): 1,401 @ $106.32 · Sale (S): 1,530 @ $107.45 · Sale (S): 900 @ $108.14 · Sale (S): 1,669 @ $109.30 · Option exercise (M): 5,500 (derivative) @ $0 | EDGAR |
| 2026-05-01 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 5,500 @ $6.89 · Sale (S): 4,418 @ $99.13 · Sale (S): 1,082 @ $99.57 · Option exercise (M): 5,500 (derivative) @ $0 | EDGAR |
| 2026-03-30 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 5,500 @ $6.89 · Sale (S): 940 @ $97.50 · Sale (S): 1,757 @ $98.21 · Sale (S): 2,803 @ $99.46 · Option exercise (M): 5,500 (derivative) @ $0 | EDGAR |
| 2026-03-02 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 5,500 @ $6.89 · Sale (S): 2,698 @ $102.64 · Sale (S): 2,602 @ $103.41 · Sale (S): 200 @ $103.96 · Option exercise (M): 5,500 (derivative) @ $0 | EDGAR |
| 2026-01-23 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 700 @ $27.85 · Sale (S): 700 @ $109.84 · Option exercise (M): 14,300 @ $27.85 · Sale (S): 14,300 @ $110.16 · Option exercise (M): 700 (derivative) @ $0 · Option exercise (M): 14,300 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Nuvalent, Inc. (NUVL) | Sale (S): 897 @ $96.06 · Sale (S): 1,153 @ $96.85 · Sale (S): 1,987 @ $97.96 · Sale (S): 326 @ $98.52 · Sale (S): 1,075 @ $96.75 · Sale (S): 1,331 @ $97.33 · +3 more | EDGAR |
| 2026-01-05 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 10,000 @ $18.93 · Sale (S): 4,005 @ $100.03 · Sale (S): 5,455 @ $100.77 · Sale (S): 540 @ $101.47 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-11-19 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 24,200 @ $6.89 · Sale (S): 15,075 @ $105.16 · Sale (S): 8,517 @ $105.98 · Sale (S): 608 @ $107.04 · Option exercise (M): 24,200 (derivative) @ $0 | EDGAR |
| 2025-10-31 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 21,800 @ $6.89 · Sale (S): 700 @ $96.65 · Sale (S): 1,273 @ $97.98 · Sale (S): 500 @ $99.66 · Sale (S): 600 @ $100.96 · Sale (S): 2,121 @ $102 · +4 more | EDGAR |
| 2025-10-22 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 5,000 @ $6.89 · Sale (S): 5,000 @ $94.91 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2025-10-17 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 15,624 @ $6.89 · Sale (S): 15,624 @ $89.98 · Option exercise (M): 12,376 @ $6.89 · Sale (S): 2,277 @ $90.54 · Sale (S): 5,199 @ $91.37 · Sale (S): 4,900 @ $92.50 · +2 more | EDGAR |
| 2025-01-08 | 4 | Nuvalent, Inc. (NUVL) | Grant/award (A): 18,750 @ $0 · Sale (S): 850 @ $78.28 · Sale (S): 510 @ $79.33 · Sale (S): 1,604 @ $80.54 · Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2024-09-18 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 8,000 @ $18.93 · Sale (S): 600 @ $93.22 · Sale (S): 1,869 @ $94.86 · Sale (S): 2,255 @ $96.43 · Sale (S): 2,297 @ $97.30 · Sale (S): 534 @ $98.34 · +3 more | EDGAR |
| 2024-09-11 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 3,000 @ $6.89 · Sale (S): 240 @ $86.34 · Sale (S): 288 @ $87.69 · Sale (S): 2,311 @ $88.37 · Sale (S): 161 @ $89.11 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2024-08-27 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 5,000 @ $18.93 · Option exercise (M): 6,000 @ $27.85 · Sale (S): 11,000 @ $85.04 · Option exercise (M): 5,000 (derivative) @ $0 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2024-08-09 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 3,000 @ $6.89 · Sale (S): 112 @ $65.66 · Sale (S): 624 @ $67.17 · Sale (S): 96 @ $67.95 · Sale (S): 1,794 @ $69.34 · Sale (S): 374 @ $69.95 · +1 more | EDGAR |
| 2024-07-16 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 6,000 @ $27.85 · Sale (S): 6,000 @ $80.16 · Option exercise (M): 6,000 (derivative) @ $0 | EDGAR |
| 2024-07-10 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 3,000 @ $6.89 · Sale (S): 562 @ $71.97 · Sale (S): 1,739 @ $73.39 · Sale (S): 699 @ $73.84 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 3,000 @ $6.89 · Option exercise (M): 5,000 @ $18.93 · Sale (S): 230 @ $73.42 · Sale (S): 750 @ $74.39 · Sale (S): 156 @ $75.81 · Sale (S): 526 @ $76.88 · +7 more | EDGAR |
| 2024-05-03 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 3,000 @ $6.89 · Sale (S): 1,566 @ $71.55 · Sale (S): 1,296 @ $72.58 · Sale (S): 138 @ $73.13 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2024-04-05 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 3,000 @ $6.89 · Sale (S): 731 @ $71.54 · Sale (S): 400 @ $72.69 · Sale (S): 378 @ $73.74 · Sale (S): 1,491 @ $74.81 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2024-03-29 | 4 | Nuvalent, Inc. (NUVL) | Option exercise (M): 13,000 @ $18.93 · Option exercise (M): 9,000 @ $27.85 · Sale (S): 2,748 @ $74.23 · Sale (S): 16,208 @ $75.22 · Sale (S): 3,044 @ $75.94 · Option exercise (M): 13,000 (derivative) @ $0 · +1 more | EDGAR |
| 2024-01-09 | 4 | Nuvalent, Inc. (NUVL) | Grant/award (A): 33,300 @ $0 · Grant/award (A): 47,500 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1868741 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →